SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Melanie J. Davies, Laura J. Gray, Jacqui Troughton, Alastair Gray, Jaakko Tuomilehto, Azhar Farooqi, Kamlesh Khunti, Thomas Yates, A community based primary prevention programme for type 2 diabetes integrating identification and lifestyle intervention for prevention: the Let's Prevent Diabetes cluster randomised controlled trial, Preventive Medicine, 2016, 84, 48

    CrossRef

  2. 2
    Daisuke Yabe, Yutaka Seino, Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation, Expert Opinion on Drug Safety, 2016, 15, 2, 249

    CrossRef

  3. 3
    Boon Chong Cheah, Alasdair Iain Macdonald, Christopher Martin, Angelos J. Streklas, Gordon Campbell, Mohammed A. Al-Rawhani, Balazs Nemeth, James P. Grant, Michael P. Barrett, David R. S. Cumming, An Integrated Circuit for Chip-Based Analysis of Enzyme Kinetics and Metabolite Quantification, IEEE Transactions on Biomedical Circuits and Systems, 2016, 10, 3, 721

    CrossRef

  4. 4
    May Ee Png, Joanne Yoong, Thao Phuong Phan, Hwee Lin Wee, Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050, BMC Public Health, 2016, 16, 1

    CrossRef

  5. 5
    R. David Hayward, Neal Krause, Gail Ironson, Peter C. Hill, Robert Emmons, Health and Well-Being Among the Non-religious: Atheists, Agnostics, and No Preference Compared with Religious Group Members, Journal of Religion and Health, 2016, 55, 3, 1024

    CrossRef

  6. 6
    Lisa Elliott, Carrie Fidler, Andrea Ditchfield, Trine Stissing, Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes, Diabetes Therapy, 2016, 7, 1, 45

    CrossRef

  7. 7
    Krzysztof Piotr Malinowski, Paweł Piotr Kawalec, Paweł Moćko, Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland, Expert Review of Pharmacoeconomics & Outcomes Research, 2016, 16, 2, 295

    CrossRef

  8. 8
    Anne Julie Overgaard, Jacquelyn M. Weir, David Peter De Souza, Dedreia Tull, Claus Haase, Peter J. Meikle, Flemming Pociot, Lipidomic and metabolomic characterization of a genetically modified mouse model of the early stages of human type 1 diabetes pathogenesis, Metabolomics, 2016, 12, 1

    CrossRef

  9. 9
    Stéphane Roze, Jayne Smith-Palmer, William J. Valentine, Mark Cook, Manisha Jethwa, Simona de Portu, John C. Pickup, Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective, Journal of Medical Economics, 2016, 19, 3, 236

    CrossRef

  10. 10
    Karen Smith, Andrew Collier, Eleanor M. Townsend, Lindsay E. O’Donnell, Abhijit M. Bal, John Butcher, William G. Mackay, Gordon Ramage, Craig Williams, One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers, BMC Microbiology, 2016, 16, 1

    CrossRef

  11. 11
    Girish Rayanagoudar, Amal A. Hashi, Javier Zamora, Khalid S. Khan, Graham A. Hitman, Shakila Thangaratinam, Quantification of the type 2 diabetes risk in women with gestational diabetes: a systematic review and meta-analysis of 95,750 women, Diabetologia, 2016,

    CrossRef

  12. 12
    Jessica Tyrrell, David J. Whinney, Timothy Taylor, The Cost of Ménière’s Disease, Ear and Hearing, 2016, 37, 3, e202

    CrossRef

  13. 13
    Wilma S. Leslie, Ian Ford, Naveed Sattar, Kieren G. Hollingsworth, Ashley Adamson, Falko F. Sniehotta, Louise McCombie, Naomi Brosnahan, Hazel Ross, John C. Mathers, Carl Peters, George Thom, Alison Barnes, Sharon Kean, Yvonne McIlvenna, Angela Rodrigues, Lucia Rehackova, Sviatlana Zhyzhneuskaya, Roy Taylor, Mike E. J. Lean, The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial, BMC Family Practice, 2016, 17, 1

    CrossRef

  14. 14
    R.T. Grimes, K. Bennett, R. Canavan, L. Tilson, M.C. Henman, The impact of initial antidiabetic agent and use of monitoring agents on prescription costs in newly treated type 2 diabetes: A retrospective cohort analysis, Diabetes Research and Clinical Practice, 2016, 113, 152

    CrossRef

  15. 15
    B. T. Blak, U. Rigney, C. Sternhufvud, J. Davis, N. Hammar, Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class, International Journal of Clinical Practice, 2016, 70, 1
  16. 16
    N.J. Gardiner, O.J. Freeman, Controversies In Diabetic Neuropathy, 2016,

    CrossRef

  17. 17
    Vivien E Coates, Adrian McCann, Natasha Posner, Kathleen Gunn, Kate Seers, ‘Well, who do I phone?’ Preparing for urgent care: a challenge for patients and service providers alike', Journal of Clinical Nursing, 2015, 24, 15-16
  18. 18
    Simone Marini, Emanuele Trifoglio, Nicola Barbarini, Francesco Sambo, Barbara Di Camillo, Alberto Malovini, Marco Manfrini, Claudio Cobelli, Riccardo Bellazzi, A Dynamic Bayesian Network model for long-term simulation of clinical complications in type 1 diabetes, Journal of Biomedical Informatics, 2015, 57, 369

    CrossRef

  19. 19
    L. G. Bowden, H. M. Byrne, P. K. Maini, D. E. Moulton, A morphoelastic model for dermal wound closure, Biomechanics and Modeling in Mechanobiology, 2015,

    CrossRef

  20. 20
    Katie Morton, Stephen Sutton, Wendy Hardeman, Jacqui Troughton, Tom Yates, Simon Griffin, Melanie Davies, Kamlesh Khunti, Helen Eborall, A Text-Messaging and Pedometer Program to Promote Physical Activity in People at High Risk of Type 2 Diabetes: The Development of the PROPELS Follow-On Support Program, JMIR mHealth and uHealth, 2015, 3, 4, e105

    CrossRef

  21. 21
    W. A. Parekh, D. Ashley, B. Chubb, H. Gillies, M. Evans, Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool, Diabetic Medicine, 2015, 32, 9
  22. 22
    Hafeez-U. R. Siddiqui, Michelle Spruce, Stephen R. Alty, Sandra Dudley, Automated Peripheral Neuropathy Assessment Using Optical Imaging and Foot Anthropometry, IEEE Transactions on Biomedical Engineering, 2015, 62, 8, 1911

    CrossRef

  23. 23
    Anat Jaffe, Aviva Yoselis, Liana Tripto-Shkolnik, Better together: a community- hospital integrative model of healthcare as a practical solution for providing excellence in endocrinology care in an era of limited resources, Israel Journal of Health Policy Research, 2015, 4, 1

    CrossRef

  24. 24
    Soulmaz Fazeli Farsani, Patrick C Souverein, Marja M J van der Vorst, Catherijne A J Knibbe, Anthonius de Boer, Aukje K Mantel-Teeuwisse, Chronic comorbidities in children with type 1 diabetes: a population-based cohort study, Archives of Disease in Childhood, 2015, 100, 8, 763

    CrossRef

  25. 25
    Marc Evans, Phil McEwan, Clinical and cost–effectiveness of insulin degludec: from clinical trials to clinical practice, Journal of Comparative Effectiveness Research, 2015, 4, 3, 279

    CrossRef

  26. 26
    J. Anstey, A. Yassaee, A. Solomon, Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review, Diabetic Medicine, 2015, 32, 10
  27. 27
    D. Simmons, T. Deakin, N. Walsh, B. Turner, S. Lawrence, L. Priest, S. George, G. Vanterpool, J. McArdle, A. Rylance, G. Terry, P. Little, Competency frameworks in diabetes, Diabetic Medicine, 2015, 32, 5
  28. 28
    Maria Dimitrova, Miglena Doneva, Vasil Valov, Stanislava Yordanova, Manoela Manova, Alexandra Savova, Konstantin Mitov, Guenka Petrova, Valentina Petkova, Marcin Czech, Cost of hospitalizations due to microvascular and macrovascular complications in type 1 and type 2 diabetic patients in Bulgaria, Biotechnology & Biotechnological Equipment, 2015, 29, 4, 805

    CrossRef

  29. 29
    M. Charokopou, P. McEwan, S. Lister, L. Callan, K. Bergenheim, K. Tolley, R. Postema, R. Townsend, M. Roudaut, Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective, BMC Health Services Research, 2015, 15, 1

    CrossRef

  30. 30
    M. Evans, M. Wolden, J. Gundgaard, B. Chubb, T. Christensen, Cost-effectiveness of insulin degludec compared with insulin glargine in a basal-bolus regimen in patients with type 1 diabetes mellitus in the UK, Journal of Medical Economics, 2015, 18, 1, 56

    CrossRef

  31. 31
    Jason Leo Walsh, Benjamin Howell Lole Harris, Aled Wyn Roberts, Evaluation of a community diabetes initiative: Integrating diabetes care, Primary Care Diabetes, 2015, 9, 3, 203

    CrossRef

  32. 32
    Jason P. Gordon, Marc Evans, Jorge Puelles, Philip C. McEwan, Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy, Diabetes Therapy, 2015, 6, 4, 495

    CrossRef

  33. 33
    Amy Jayne McKnight, Seamus Duffy, Alexander P. Maxwell, Genetics of Diabetic Nephropathy: a Long Road of Discovery, Current Diabetes Reports, 2015, 15, 7

    CrossRef

  34. 34
    Evangelos Kontopantelis, David A. Springate, David Reeves, Darren M. Ashcroft, Martin Rutter, Iain Buchan, Tim Doran, Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study, Diabetologia, 2015, 58, 3, 505

    CrossRef

  35. 35
    Harriet A. Carroll, Mark G. Davis, Angeliki Papadaki, Higher plain water intake is associated with lower type 2 diabetes risk: a cross-sectional study in humans, Nutrition Research, 2015, 35, 10, 865

    CrossRef

  36. 36
    Paul Grant, How much does a diabetes out-patient appointment actually cost? An argument for PLICS, Journal of Health Organization and Management, 2015, 29, 2, 154

    CrossRef

  37. 37
    L. Low, J. P. Law, J. Hodson, R. McAlpine, U. O'Colmain, C. MacEwen, Impact of socioeconomic deprivation on the development of diabetic retinopathy: a population-based, cross-sectional and longitudinal study over 12 years, BMJ Open, 2015, 5, 4, e007290

    CrossRef

  38. 38
    Anthony H Barnett, In defence of NICE draft type 2 diabetes guidelines – Author's reply, The Lancet Diabetes & Endocrinology, 2015, 3, 6, 406

    CrossRef

  39. 39
    Rafael Simó, Olga Simó-Servat, Cristina Hernández, Is Fenofibrate a Reasonable Treatment for Diabetic Microvascular Disease?, Current Diabetes Reports, 2015, 15, 5

    CrossRef

  40. 40
    Anna McLister, James Davis, Molecular Wiring in Smart Dressings: Opening a New Route to Monitoring Wound pH, Healthcare, 2015, 3, 3, 466

    CrossRef

  41. 41
    Jason Seewoodhary, Stephen Phooi Yew Wong, New insulins for diabetes, Practical Diabetes, 2015, 32, 3
  42. 42
    M. G. McGrady, J. Pickford, E. Hawthorn, J. Waterall, C. Bridgman, NHS Health Checks in a primary care dental setting – an opportunity for the profession to maximise uptake for public health partners?, BDJ, 2015, 219, 3, 107

    CrossRef

  43. 43
    John W. Stevens, Kamlesh Khunti, Rebecca Harvey, Maxine Johnson, Louise Preston, Helen Buckley Woods, Melanie Davies, Elizabeth Goyder, Preventing the progression to Type 2 diabetes mellitus in adults at high risk: A systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions, Diabetes Research and Clinical Practice, 2015, 107, 3, 320

    CrossRef

  44. 44
    Linda Ann Savas, Katherine Grady, Sarah Cotterill, Lucinda Summers, Ruth Boaden, J. Martin Gibson, Prioritising prevention: Implementation of IGT Care Call, a telephone based service for people at risk of developing type 2 diabetes, Primary Care Diabetes, 2015, 9, 1, 3

    CrossRef

  45. 45
    Tom Yates, Simon Griffin, Danielle H Bodicoat, Gwen Brierly, Helen Dallosso, Melanie J Davies, Helen Eborall, Charlotte Edwardson, Mike Gillett, Laura Gray, Wendy Hardeman, Sian Hill, Katie Morton, Stephen Sutton, Jacqui Troughton, Kamlesh Khunti, PRomotion Of Physical activity through structured Education with differing Levels of ongoing Support for people at high risk of type 2 diabetes (PROPELS): study protocol for a randomized controlled trial, Trials, 2015, 16, 1

    CrossRef

  46. 46
    Mahiben Maruthappu, Harpreet Sood, Bruce Keogh, Radically upgrading diabetes prevention in England, The Lancet Diabetes & Endocrinology, 2015, 3, 5, 312

    CrossRef

  47. 47
    Emma Derbyshire, Carrie Ruxton, Red meat consumption and type 2 diabetes mellitus risk, Nutrition & Food Science, 2015, 45, 4, 524

    CrossRef

  48. 48
    P. McEwan, H. Bennett, T. Ward, K. Bergenheim, Refitting of the UKPDS 68 Risk Equations to Contemporary Routine Clinical Practice Data in the UK, PharmacoEconomics, 2015, 33, 2, 149

    CrossRef

  49. 49
    Yeganeh Manon Khazrai, Raffaella Buzzetti, Stefano Del Prato, Avivit Cahn, Itamar Raz, Paolo Pozzilli, The addition of E (Empowerment and Economics) to the ABCD algorithm in diabetes care, Journal of Diabetes and its Complications, 2015, 29, 4, 599

    CrossRef

  50. 50
    Jur-Shan Cheng, Wen-Chen Tsai, Chen-Li Lin, Likwang Chen, Hui-Chu Lang, Hui-Min Hsieh, Shyi-Jang Shin, Ted Chen, Chi-Ting Huang, Chih-Cheng Hsu, Trend and Factors Associated With Healthcare Use and Costs in Type 2 Diabetes Mellitus, Medical Care, 2015, 53, 2, 116

    CrossRef

  51. 51
    Connor A. Emdin, Simon G. Anderson, Mark Woodward, Kazem Rahimi, Usual Blood Pressure and Risk of New-Onset Diabetes, Journal of the American College of Cardiology, 2015, 66, 14, 1552

    CrossRef

  52. 52
    Philip McEwan, Thomas Ward, Hayley Bennett, Klas Bergenheim, Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model, Cost Effectiveness and Resource Allocation, 2015, 13, 1

    CrossRef

  53. 53
    Iain Willits, Helen Cole, Roseanne Jones, Paul Dimmock, Mick Arber, Joyce Craig, Andrew Sims, VibraTip™ for Testing Vibration Perception to Detect Diabetic Peripheral Neuropathy: A NICE Medical Technology Guidance, Applied Health Economics and Health Policy, 2015, 13, 4, 315

    CrossRef

  54. 54
    Yutaka Seino, Daisuke Yabe, Alogliptin benzoate for the treatment of type 2 diabetes, Expert Opinion on Pharmacotherapy, 2014, 15, 6, 851

    CrossRef

  55. 55
    L.G. Bowden, P.K. Maini, D.E. Moulton, J.B. Tang, X.T. Wang, P.Y. Liu, H.M. Byrne, An ordinary differential equation model for full thickness wounds and the effects of diabetes, Journal of Theoretical Biology, 2014, 361, 87

    CrossRef

  56. 56
    R. Brett McQueen, Samuel L. Ellis, David M. Maahs, Heather D. Anderson, Kavita V. Nair, Anne M. Libby, Jonathan D. Campbell, Association Between Glycated Hemoglobin and Health Utility for Type 1 Diabetes, The Patient - Patient-Centered Outcomes Research, 2014, 7, 2, 197

    CrossRef

  57. 57
    Jorge F. Elgart, Joaquín E. Caporale, Santiago Asteazarán, Jorge L. De La Fuente, Cecilia Camilluci, Jonathan B. Brown, Claudio D. González, Juan J. Gagliardino, Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina, Diabetes Research and Clinical Practice, 2014, 104, 2, 241

    CrossRef

  58. 58
    Kristien Acker, Philippe Léger, Agnes Hartemann, Abhineet Chawla, Mohd Kashif Siddiqui, Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review, Diabetes/Metabolism Research and Reviews, 2014, 30, 8
  59. 59
    M. Evans, M. Wolden, J. Gundgaard, B. Chubb, T. Christensen, Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin – from the UK health care cost perspective, Diabetes, Obesity and Metabolism, 2014, 16, 4
  60. 60
    R. Sagarra, B. Costa, J.J. Cabré, O. Solà-Morales, F. Barrio, Coste-efectividad de la intervención sobre el estilo de vida para prevenir la diabetes tipo 2, Revista Clínica Española, 2014, 214, 2, 59

    CrossRef

  61. 61
    Joanna Leśniowska, Agata Schubert, Michał Wojna, Iwona Skrzekowska-Baran, Marta Fedyna, Costs of diabetes and its complications in Poland, The European Journal of Health Economics, 2014, 15, 6, 653

    CrossRef

  62. 62
    Jorge F. Elgart, Santiago Asteazarán, Jorge L. De La Fuente, Cecilia Camillucci, Jonathan B. Brown, Juan José Gagliardino, Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina, International Journal of Public Health, 2014, 59, 5, 851

    CrossRef

  63. 63
    A. Calderón-Larrañaga, M. Soljak, E. Cecil, J. Valabhji, D. Bell, A. Prados Torres, A. Majeed, Does higher quality of primary healthcare reduce hospital admissions for diabetes complications? A national observational study, Diabetic Medicine, 2014, 31, 6
  64. 64
    P. Souto Barreto, C. Sanz, B. Vellas, M. Lapeyre-Mestre, Y. Rolland, Drug treatment for diabetes in nursing home residents, Diabetic Medicine, 2014, 31, 5
  65. 65
    A. Malhotra, M. Maruthappu, T. Stephenson, Healthy eating: an NHS priority A sure way to improve health outcomes for NHS staff and the public, Postgraduate Medical Journal, 2014, 90, 1070, 671

    CrossRef

  66. 66
    Simon Heller, Julia Lawton, Stephanie Amiel, Debbie Cooke, Peter Mansell, Alan Brennan, Jackie Elliott, Jonathan Boote, Celia Emery, Wendy Baird, Hasan Basarir, Susan Beveridge, Rod Bond, Mike Campbell, Timothy Chater, Pratik Choudhary, Marie Clark, Nicole de Zoysa, Simon Dixon, Carla Gianfrancesco, David Hopkins, Richard Jacques, Jen Kruger, Susan Moore, Lindsay Oliver, Tessa Peasgood, David Rankin, Sue Roberts, Helen Rogers, Carolin Taylor, Praveen Thokala, Gill Thompson, Candice Ward, Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes, Programme Grants for Applied Research, 2014, 2, 5, 1

    CrossRef

  67. 67
    Kamlesh Khunti, Xavier Cos, Guy Rutten, Insulin degludec – The impact of a new basal insulin on care in type 2 diabetes, Primary Care Diabetes, 2014, 8, 2, 119

    CrossRef

  68. 68
    R. Sagarra, B. Costa, J.J. Cabré, O. Solà-Morales, F. Barrio, Lifestyle interventions for diabetes mellitus type 2 prevention, Revista Clínica Española (English Edition), 2014, 214, 2, 59

    CrossRef

  69. 69
    Kate Wicks, Tanja Torbica, Kimberly A. Mace, Myeloid cell dysfunction and the pathogenesis of the diabetic chronic wound, Seminars in Immunology, 2014, 26, 4, 341

    CrossRef

  70. 70
    P. Aldam, N. Levy, G. M. Hall, Perioperative management of diabetic patients: new controversies, British Journal of Anaesthesia, 2014, 113, 6, 906

    CrossRef

  71. 71
    Silvia Paz, Diego González Segura, Anna Raya Torres, Luis Lizan, Principales factores asociados al coste de la diabetes mellitus tipo 2: revisión de la literatura, Avances en Diabetología, 2014, 30, 2, 34

    CrossRef

  72. 72
    J. M. Khalid, M. Raluy-Callado, B. H. Curtis, K. S. Boye, A. Maguire, M. Reaney, Rates and risk of hospitalisation among patients with type 2 diabetes: retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics, International Journal of Clinical Practice, 2014, 68, 1
  73. 73
    Amélie Beaudet, John Clegg, Per-Olof Thuresson, Adam Lloyd, Phil McEwan, Review of Utility Values for Economic Modeling in Type 2 Diabetes, Value in Health, 2014, 17, 4, 462

    CrossRef

  74. 74
    Muhammad Khan, Keith Broadbent, Mike Morris, David Ewins, Franklin Joseph, System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System, Disease Markers, 2014, 2014, 1

    CrossRef

  75. 75
    Mary E. Costantino, Jane N. Stacy, Frank Song, Yihua Xu, Jonathan R. Bouchard, The Burden of Diabetes Mellitus for Medicare Beneficiaries, Population Health Management, 2014, 17, 5, 272

    CrossRef

  76. 76
    Phil McEwan, Volker Foos, James L. Palmer, Mark Lamotte, Adam Lloyd, David Grant, Validation of the IMS CORE Diabetes Model, Value in Health, 2014, 17, 6, 714

    CrossRef

  77. 77
    Clive Petry, Gestational Diabetes, 2014,

    CrossRef

  78. 78
    G. E. McVeigh, W. Gibson, P. K. Hamilton, Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease, Diabetes, Obesity and Metabolism, 2013, 15, 3
  79. 79
    Miglena Doneva, Vasil Valov, Anna-Maria Borisova, Tsvetalina Tankova, Alexandra Savova, Manoela Manova, Marcin Czech, Guenka Petrova, Comparative Analysis of the Cost of Insulin Treated Patients in Bulgaria, Biotechnology & Biotechnological Equipment, 2013, 27, 2, 3748

    CrossRef

  80. 80
    Gemma Rojo-Martínez, Sergio Valdés, Natalia Colomo, M. Isabel Lucena, Sonia Gaztambide, Ramón Gomis, Roser Casamitjana, Rafael Carmena, Miguel Catalá, María T. Martínez-Larrad, Manuel Serrano-Ríos, Luis Castaño, Joan Vendrell, Juan Girbés, Josep Franch, José A. Vázquez, Inmaculada Mora-Peces, Inés Urrutia, Gemma Pascual-Manich, Emilio Ortega, Edelmiro Menéndez, Elias Delgado, Elena Bordiú, Conxa Castell, Alfonso López-Alba, Alberto Goday, Alfonso Calle, Anna Bosch-Comas, Federico Soriguer, Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es, Revista Española de Cardiología, 2013, 66, 11, 854

    CrossRef

  81. 81
    G. Penno, A. Solini, E. Bonora, C. Fondelli, E. Orsi, G. Zerbini, R. Trevisan, M. Vedovato, G. Gruden, L. Laviola, A. Nicolucci, G. Pugliese, Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study, Journal of Internal Medicine, 2013, 274, 2
  82. 82
    A.H. Barnett, R. Brice, W. Hanif, J. James, H. Langerman, Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents, Current Medical Research and Opinion, 2013, 29, 11, 1503

    CrossRef

  83. 83
    Magnus Falk, Viktor Andoralov, Maria Silow, Miguel D. Toscano, Sergey Shleev, Miniature Biofuel Cell as a Potential Power Source for Glucose-Sensing Contact Lenses, Analytical Chemistry, 2013, 85, 13, 6342

    CrossRef

  84. 84
    MJ Taylor, TS Sahota, New technologies in insulin delivery, Practical Diabetes, 2013, 30, 1
  85. 85
    R. Waldeyer, R. Brinks, W. Rathmann, G. Giani, A. Icks, Projection of the burden of Type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040, Diabetic Medicine, 2013, 30, 8
  86. 86
    Torsten Lauritzen, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy EHM Rutten, Annelli Sandbæk, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham, Simon J Griffin, Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?, Diabetes Management, 2013, 3, 5, 367

    CrossRef

  87. 87
    Gemma Rojo-Martínez, Sergio Valdés, Natalia Colomo, M. Isabel Lucena, Sonia Gaztambide, Ramón Gomis, Roser Casamitjana, Rafael Carmena, Miguel Catalá, María T. Martínez-Larrad, Manuel Serrano-Ríos, Luis Castaño, Joan Vendrell, Juan Girbés, Josep Franch, José A. Vázquez, Inmaculada Mora-Peces, Inés Urrutia, Gemma Pascual-Manich, Emilio Ortega, Edelmiro Menéndez, Elias Delgado, Elena Bordiú, Conxa Castell, Alfonso López-Alba, Alberto Goday, Alfonso Calle, Anna Bosch-Comas, Federico Soriguer, Use of Drugs Related to the Treatment of Diabetes Mellitus and Other Cardiovascular Risk Factors in the Spanish Population. The Di@bet.es Study, Revista Española de Cardiología (English Edition), 2013, 66, 11, 854

    CrossRef

  88. 88
    Tien-Jyun Chang, Yi-Der Jiang, Chia-Hsiun Chang, Ching-Hu Chung, Neng-Chun Yu, Lee-Ming Chuang, Accountability, utilization and providers for diabetes management in Taiwan, 2000–2009: An analysis of the National Health Insurance database, Journal of the Formosan Medical Association, 2012, 111, 11, 605

    CrossRef

  89. 89
    Eleanor Kennedy, David R Matthews, Do clinical research networks work? The NIHR diabetes research network after 6 years, Clinical Investigation, 2012, 2, 10, 971

    CrossRef

  90. 90
    James Jarrett, James Woodcock, Ulla K Griffiths, Zaid Chalabi, Phil Edwards, Ian Roberts, Andy Haines, Effect of increasing active travel in urban England and Wales on costs to the National Health Service, The Lancet, 2012, 379, 9832, 2198

    CrossRef

  91. 91
    Lynda M. Williams, Hypothalamic dysfunction in obesity, Proceedings of the Nutrition Society, 2012, 71, 04, 521

    CrossRef

  92. 92
    Eleanor D Kennedy, David R Matthews, NIHR Diabetes Research Network: the gold standard for clinical trials?, Practical Diabetes, 2012, 29, 8
  93. You have free access to this content93
    Madeleine Attridge, John Creamer, Michael Ramsden, Rebecca Cannings-John, Kamila Hawthorne, Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus, The Cochrane Library,
  94. 94
    References,
  95. 95
    Rhys Williams, The economics of diabetes care: a global perspective,
  96. 96
    Terry C Simpson, Jo C Weldon, Helen V Worthington, Ian Needleman, Sarah H Wild, David R Moles, Brian Stevenson, Susan Furness, Zipporah Iheozor-Ejiofor, Treatment of periodontal disease for glycaemic control in people with diabetes mellitus, The Cochrane Library,